Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
- 23 May 2005
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 4 (7) , 468-474
- https://doi.org/10.1016/j.autrev.2005.04.018
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritisAnnals of the Rheumatic Diseases, 2005
- Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritisAnnals of the Rheumatic Diseases, 2005
- Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2005
- Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2005
- Antibodies against cyclic citrullinated peptide are associated with HLA–DR4 in simplex and multiplex polyarticular‐onset juvenile rheumatoid arthritisArthritis & Rheumatism, 2005
- Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti–cyclic citrullinated peptide antibodyArthritis & Rheumatism, 2004
- Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvementAnnals of the Rheumatic Diseases, 2004
- Absence of citrulline‐specific autoantibodies in animal models of autoimmunityArthritis & Rheumatism, 2004
- Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseasesAnnals of the Rheumatic Diseases, 2004
- Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritisAnnals of the Rheumatic Diseases, 2002